Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 498

1.

IPVS statement on "Temporary HPV vaccine shortage: Implications globally to achieve equity".

Garland SM, Stanley MA, Giuliano AR, Moscicki AB, Kaufmann A, Bhatla N, Woo YL; IPVS Policy Committee.

Papillomavirus Res. 2020 Mar 20;9:100195. doi: 10.1016/j.pvr.2020.100195. [Epub ahead of print] No abstract available.

2.

Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations.

Murray GL, Bodiyabadu K, Danielewski J, Garland SM, Machalek DA, Fairley CK, Jensen JS, Williamson DA, Tan LY, Mokany E, Durukan D, Bradshaw CS.

J Infect Dis. 2020 Mar 2;221(6):1017-1024. doi: 10.1093/infdis/jiz550.

PMID:
32031634
3.

Point-of-care testing and treatment of sexually transmitted infections to improve birth outcomes in high-burden, low-income settings: Study protocol for a cluster randomized crossover trial (the WANTAIM Trial, Papua New Guinea).

Vallely AJ, Pomat WS, Homer C, Guy R, Luchters S, Mola GDL, Kariwiga G, Vallely LM, Wiseman V, Morgan C, Wand H, Rogerson SJ, Tabrizi SN, Whiley DM, Low N, Peeling R, Siba P, Riddell M, Laman M, Bolnga J, Robinson LJ, Morewaya J, Badman SG, Batura N, Kelly-Hanku A, Toliman PJ, Peter W, Babona D, Peach E, Garland SM, Kaldor JM.

Wellcome Open Res. 2019 Mar 22;4:53. doi: 10.12688/wellcomeopenres.15173.2. eCollection 2019.

4.

Using Facebook to Improve Participation Among 25-Year-Olds Enrolled in a Longitudinal Preterm Birth Cohort Study.

Haikerwal A, Doyle LW, Patton G, Wark JD, Garland SM, Burnett AC, Cheong JLY.

Acad Pediatr. 2020 Jan 25. pii: S1876-2859(20)30010-3. doi: 10.1016/j.acap.2020.01.008. [Epub ahead of print]

PMID:
31987891
5.

Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits.

Murray GL, Danielewski J, Bradshaw CS, Williamson DA, Birnie J, Su JP, De Petra V, Tan LY, Wee R, Machalek DA, Read TRH, Garland SM.

J Med Microbiol. 2020 Feb;69(2):244-248. doi: 10.1099/jmm.0.001140. Epub 2020 Jan 20.

PMID:
31958047
6.

Prevalence and associations of larger burden of intra-anal high-grade squamous intraepithelial lesions at baseline in an Australian cohort of gay and bisexual men: The Study of the Prevention of Anal Cancer.

Templeton DJ, Williamson C, Jin F, Hillman RJ, Roberts JM, Law C, Fairley CK, Garland SM, Grulich AE, Poynten IM; Study of the Prevention of Anal Cancer (SPANC) Research Team.

Cancer Epidemiol. 2020 Feb;64:101661. doi: 10.1016/j.canep.2019.101661. Epub 2020 Jan 7.

PMID:
31918181
7.

Long-term trends of Chlamydia trachomatis in a clinic population at the Royal Women's Hospital, Melbourne.

Garland SM, Subasinghe AK, Ahmed N, Jayasinghe Y, Marceglia A.

Aust N Z J Obstet Gynaecol. 2020 Feb;60(1):149-153. doi: 10.1111/ajo.13106. Epub 2019 Dec 27.

PMID:
31881110
8.

Sexual practices have a significant impact on the vaginal microbiota of women who have sex with women.

Plummer EL, Vodstrcil LA, Fairley CK, Tabrizi SN, Garland SM, Law MG, Hocking JS, Fethers KA, Bulach DM, Murray GL, Bradshaw CS.

Sci Rep. 2019 Dec 24;9(1):19749. doi: 10.1038/s41598-019-55929-7.

9.

IPVS Policy Statement addressing the burden of HPV disease for Indigenous peoples.

Lawton B, Heffernan M, Wurtak G, Steben M, Lhaki P, Cram F, Blas M, Hibma M, Adcock A, Stevenson K, Whop L, Brotherton J, Garland SM.

Papillomavirus Res. 2019 Dec 12;9:100191. doi: 10.1016/j.pvr.2019.100191. [Epub ahead of print] No abstract available.

10.

Selective Persistence of HPV Cross-Neutralising Antibodies following Reduced-Dose HPV Vaccine Schedules.

Toh ZQ, Kosasih J, Russell FM, Reyburn R, Fong J, Tuivaga E, Ratu FT, Nguyen CD, Matanitobua S, Do LAH, Menheniott T, Frazer IH, Garland SM, Mulholland EK, Licciardi PV.

Vaccines (Basel). 2019 Nov 28;7(4). pii: E200. doi: 10.3390/vaccines7040200.

11.

Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening.

Shilling H, Murray G, Brotherton JML, Hawkes D, Saville M, Sivertsen T, Chambers I, Roberts J, Farnsworth A, Garland SM, Hocking JS, Kaldor J, Guy R, Atchison S, Costa AM, Molano M, Machalek DA.

Vaccine. 2020 Jan 29;38(5):1186-1193. doi: 10.1016/j.vaccine.2019.11.019. Epub 2019 Nov 22.

PMID:
31767467
12.

Prophylactic vaccination against human papillomaviruses to prevent vulval and vaginal cancer and their precursors.

Xu L, Selk A, Garland SM, Bogliatto F, Kyrgiou M, Weyers S, Arbyn M.

Expert Rev Vaccines. 2019 Nov;18(11):1157-1166. doi: 10.1080/14760584.2019.1692658. Epub 2019 Dec 2.

PMID:
31718338
13.

Bacterial Load of Chlamydia trachomatis in the Posterior Oropharynx, Tonsillar Fossae, and Saliva among Men Who Have Sex with Men with Untreated Oropharyngeal Chlamydia.

Phillips TR, Fairley CK, Maddaford K, Danielewski J, Hocking JS, Lee D, Williamson DA, Murray G, Kong F, De Petra V, Bradshaw CS, Chen MY, Wigan R, Snow A, Howden BP, Garland SM, Chow EPF.

J Clin Microbiol. 2019 Dec 23;58(1). pii: e01375-19. doi: 10.1128/JCM.01375-19. Print 2019 Dec 23.

PMID:
31694973
14.

Postnatal probiotics and allergic disease in very preterm infants: Sub-study to the ProPrems randomized trial.

Plummer EL, Chebar Lozinsky A, Tobin JM, Uebergang JB, Axelrad C, Garland SM, Jacobs SE, Tang MLK; ProPrems Study Group.

Allergy. 2020 Jan;75(1):127-136. doi: 10.1111/all.14088. Epub 2019 Nov 8.

PMID:
31608448
15.

Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014-2017.

Chow EPF, Tabrizi SN, Fairley CK, Wigan R, Machalek DA, Regan DG, Hocking JS, Garland SM, Cornall AM, Atchison S, Bradshaw CS, McNulty A, Owen L, Marshall L, Russell DB, Kaldor JM, Chen MY.

Vaccine. 2019 Oct 31;37(46):6907-6914. doi: 10.1016/j.vaccine.2019.09.052. Epub 2019 Sep 24.

PMID:
31562001
16.

Gardnerella vaginalis Clade Distribution Is Associated With Behavioral Practices and Nugent Score in Women Who Have Sex With Women.

Plummer EL, Vodstrcil LA, Murray GL, Fairley CK, Danielewski JA, Garland SM, Chow EPF, Bulach DM, Fethers KA, Hocking JS, Bradshaw CS.

J Infect Dis. 2020 Jan 14;221(3):454-463. doi: 10.1093/infdis/jiz474.

PMID:
31544206
17.

Anal human papillomavirus infections in young unvaccinated men who have sex with men attending a sexual health clinic for HPV vaccination in Melbourne, Australia.

Chow EPF, Danielewski JA, Murray GL, Fehler G, Chen MY, Bradshaw CS, Garland SM, Fairley CK.

Vaccine. 2019 Oct 8;37(43):6271-6275. doi: 10.1016/j.vaccine.2019.08.066. Epub 2019 Sep 11.

PMID:
31521414
18.

Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (qPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium.

Fernández-Huerta M, Bodiyabadu K, Esperalba J, Bradshaw CS, Serra-Pladevall J, Garland SM, Fernández-Naval C, Jensen JS, Pumarola T, Ebeyan S, Lundgren M, Tan LY, Espasa M, Murray GL.

J Clin Microbiol. 2019 Oct 23;57(11). pii: e00886-19. doi: 10.1128/JCM.00886-19. Print 2019 Nov.

19.

Recombinant human papillomavirus nonavalent vaccine in the prevention of cancers caused by human papillomavirus.

Toh ZQ, Kosasih J, Russell FM, Garland SM, Mulholland EK, Licciardi PV.

Infect Drug Resist. 2019 Jul 4;12:1951-1967. doi: 10.2147/IDR.S178381. eCollection 2019. Review.

20.

HPV genoprevalence and HPV knowledge in young women in Mongolia, five years following a pilot 4vHPV vaccination campaign.

Batmunkh T, von Mollendorf C, Tulgaa K, Surenjav U, Dalmau MT, Namjil N, Tsedevdamba B, Tsegmed S, Enkhmaa J, Garland SM, Mulholland K.

Papillomavirus Res. 2019 Dec;8:100175. doi: 10.1016/j.pvr.2019.100175. Epub 2019 Jul 2.

21.

Risk of newly detected infections and cervical abnormalities in adult women seropositive or seronegative for naturally acquired HPV-16/18 antibodies.

Rosillon D, Baril L, Del Rosario-Raymundo MR, Wheeler CM, Skinner SR, Garland SM, Salmeron J, Lazcano-Ponce E, Vallejos CS, Stoney T, Ter Harmsel B, Lim TYK, Quek SC, Minkina G, McNeil SA, Bouchard C, Fong KL, Money D, Ilancheran A, Savicheva A, Cruickshank M, Chatterjee A, Fiander A, Martens M, Bozonnat MC, Struyf F, Dubin G, Castellsagué X.

Cancer Med. 2019 Aug;8(10):4938-4953. doi: 10.1002/cam4.1879. Epub 2019 Jul 5.

22.

Analysis of Infection Loads in Mycoplasma genitalium Clinical Specimens by Use of a Commercial Diagnostic Test.

Murray GL, Danielewski J, Bodiyabadu K, Machalek DA, Bradshaw CS, Costa AM, Birnie J, Garland SM.

J Clin Microbiol. 2019 Aug 26;57(9). pii: e00344-19. doi: 10.1128/JCM.00344-19. Print 2019 Sep.

23.

The impact of sample storage on molecular-based detection of Mycoplasma genitalium.

Murray GL, Su JP, Birnie J, Danielewski J, Machalek DA, Bradshaw CS, Read TRH, Costa AM, Garland SM.

J Appl Microbiol. 2019 Oct;127(4):1219-1223. doi: 10.1111/jam.14359. Epub 2019 Jul 2.

PMID:
31220405
24.

Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program.

Machalek DA, Roberts JM, Garland SM, Thurloe J, Richards A, Chambers I, Sivertsen T, Farnsworth A.

Med J Aust. 2019 Aug;211(3):113-119. doi: 10.5694/mja2.50223. Epub 2019 Jun 5.

PMID:
31168828
25.

Awareness of human papillomavirus, cervical cancer and its prevention among primigravid antenatal clinic attendees in a tertiary care hospital in Sri Lanka: a cross-sectional study.

de Silva AHW, Samarawickrema N, Kasturiratne A, Skinner SR, Wickremasinghe AR, Garland SM.

Sex Health. 2019 Jun;16(3):212-217. doi: 10.1071/SH18080.

PMID:
31088609
26.

Impact of extreme prematurity or extreme low birth weight on young adult health and well-being: the Victorian Infant Collaborative Study (VICS) 1991-1992 Longitudinal Cohort study protocol.

Cheong JLY, Wark JD, Cheung MM, Irving L, Burnett AC, Lee KJ, Garland SM, Smallwood D, Patton GC, Haikerwal A, Doyle LW; Victorian Infant Collaborative Study Group.

BMJ Open. 2019 May 9;9(5):e030345. doi: 10.1136/bmjopen-2019-030345.

27.

Associations Between Serum Sodium Concentration and Bone Health Measures in Individuals Who Use Antiepileptic Drugs: A Pilot Study.

Park YA, Subasinghe AK, Ahmad BS, Gorelik A, Garland SM, Clifford V, Chiang C, Robinson H, Wark JD.

J Clin Densitom. 2019 Mar 23. pii: S1094-6950(19)30004-6. doi: 10.1016/j.jocd.2019.03.007. [Epub ahead of print] No abstract available.

PMID:
31036448
28.

Compliance with screening for and recommended management of maternal group B streptococcus carriage in pregnancy.

Moorhead R, Daley AJ, Lee LY, Gorelik A, Garland SM.

Aust N Z J Obstet Gynaecol. 2019 Dec;59(6):837-842. doi: 10.1111/ajo.12977. Epub 2019 Apr 25.

PMID:
31020650
29.

Prevalence, incidence and predictors of anal Chlamydia trachomatis, anal Neisseria gonorrhoeae and syphilis among older gay and bisexual men in the longitudinal Study for the Prevention of Anal Cancer (SPANC).

Goddard SL, Poynten IM, Petoumenous K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Templeton DJ; Study for the Prevention of Anal Cancer (SPANC) Research Team.

Sex Transm Infect. 2019 Nov;95(7):477-483. doi: 10.1136/sextrans-2019-054011. Epub 2019 Apr 24.

PMID:
31018992
30.

Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population.

Giuliano AR, Joura EA, Garland SM, Huh WK, Iversen OE, Kjaer SK, Ferenczy A, Kurman RJ, Ronnett BM, Stoler MH, Bautista OM, Moeller E, Ritter M, Shields C, Luxembourg A.

Gynecol Oncol. 2019 Jul;154(1):110-117. doi: 10.1016/j.ygyno.2019.03.253. Epub 2019 Apr 11.

31.

Cross-sectional study estimating the psychosocial impact of genital warts and other anogenital diseases in South Korea.

Lee TS, Kothari-Talwar S, Singhal PK, Yee K, Kulkarni A, Lara N, Roset M, Giuliano AR, Garland SM, Ju W.

BMJ Open. 2019 Mar 20;9(3):e025035. doi: 10.1136/bmjopen-2018-025035.

32.

Symptoms, Sites, and Significance of Mycoplasma genitalium in Men Who Have Sex with Men.

Read TRH, Murray GL, Danielewski JA, Fairley CK, Doyle M, Worthington K, Su J, Mokany E, Tan LT, Lee D, Vodstrcil LA, Chow EPF, Garland SM, Chen MY, Bradshaw CS.

Emerg Infect Dis. 2019 Apr;25(4):719-727. doi: 10.3201/eid2504.181258.

33.

Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.

Velentzis LS, Smith MA, Simms KT, Lew JB, Hall M, Hughes S, Yuill S, Killen J, Keane A, Butler K, Darlington-Brown J, Hui H, Brotherton JML, Skinner R, Brand A, Roeske L, Heley S, Carter J, Bateson D, Frazer I, Garland SM, Guy R, Hammond I, Grogan P, Arbyn M, Castle PE, Saville M, Armstrong BK, Canfell K.

Gynecol Oncol. 2019 Mar;152(3):465-471. doi: 10.1016/j.ygyno.2018.12.019.

PMID:
30876490
34.

Incidence, Clearance, and Persistence of Anal Human Papillomavirus in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Implications for Human Papillomavirus Vaccination.

Ong JJ, Walker S, Grulich A, Hoy J, Read TRH, Bradshaw C, Chen M, Garland SM, Cornall A, Hillman R, Templeton DJ, Hocking J, Eu B, Tee BK, Chow EPF, Fairley CK.

Sex Transm Dis. 2019 Apr;46(4):229-233. doi: 10.1097/OLQ.0000000000000958.

PMID:
30870323
35.

Using Mobile Technology to Improve Bone-Related Lifestyle Risk Factors in Young Women With Low Bone Mineral Density: Feasibility Randomized Controlled Trial.

Subasinghe AK, Garland SM, Gorelik A, Tay I, Wark JD.

JMIR Form Res. 2019 Feb 25;3(1):e9435. doi: 10.2196/formative.9435.

36.

Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact.

Brotherton JM, Hawkes D, Sultana F, Malloy MJ, Machalek DA, Smith MA, Garland SM, Saville M.

Vaccine. 2019 Jan 14;37(3):412-416. doi: 10.1016/j.vaccine.2018.11.075. Epub 2018 Dec 11.

PMID:
30551987
37.

Incidence, Clearance and Persistence of Anal HPV in Men who Have Sex with Men Living with HIV: Implications for HPV Vaccination.

Ong JJ, Walker S, Grulich A, Hoy J, Read TRH, Bradshaw C, Chen M, Garland SM, Hillman R, Templeton DJ, Hocking J, Eu B, Tee BK, Chow EPF, Fairley CK.

Sex Transm Dis. 2018 Nov 30. doi: 10.1097/OLQ.0000000000000958. [Epub ahead of print]

PMID:
30507634
38.

Incorporating digital anorectal examinations for anal cancer screening into routine HIV care for men who have sex with men living with HIV: a prospective cohort study.

Ong JJ, Walker S, Grulich A, Hoy J, Read TR, Bradshaw C, Chen M, Garland SM, Hillman R, Templeton DJ, Hocking J, Eu B, Tee BK, Chow EPF, Fairley CK.

J Int AIDS Soc. 2018 Dec;21(12):e25192. doi: 10.1002/jia2.25192.

39.

Association of anal symptoms with anal high grade squamous intraepithelial lesions (HSIL) among men who have sex with men: Baseline data from the study of the prevention of anal cancer (SPANC).

Goddard SL, Templeton DJ, Petoumenos K, Jin F, Hillman RJ, Law C, Roberts JM, Fairley CK, Garland SM, Grulich AE, Poynten IM; Study for the Prevention of Anal Cancer (SPANC) Research Team.

Cancer Epidemiol. 2019 Feb;58:12-16. doi: 10.1016/j.canep.2018.10.009. Epub 2018 Nov 12.

PMID:
30439602
40.

Gut microbiota of preterm infants supplemented with probiotics: sub-study of the ProPrems trial.

Plummer EL, Bulach DM, Murray GL, Jacobs SE, Tabrizi SN, Garland SM; ProPrems Study Group.

BMC Microbiol. 2018 Nov 13;18(1):184. doi: 10.1186/s12866-018-1326-1.

41.

Performance of clinical screening algorithms comprising point-of-care HPV-DNA testing using self-collected vaginal specimens, and visual inspection of the cervix with acetic acid, for the detection of underlying high-grade squamous intraepithelial lesions in Papua New Guinea.

Toliman PJ, Kaldor JM, Badman SG, Gabuzzi J, Silim S, Kumbia A, Kombuk B, Kombati Z, Munnull G, Guy R, Vallely LM, Kelly-Hanku A, Wand H, Ryan C, Tan G, Brotherton J, Saville M, Mola GDL, Garland SM, Tabrizi SN, Vallely AJ.

Papillomavirus Res. 2018 Dec;6:70-76. doi: 10.1016/j.pvr.2018.10.009. Epub 2018 Nov 1.

42.

Development of a rapid colorimetric multiplex PCR-reverse line blot for the detection and typing of 14 Chlamydia trachomatis genovars.

Molano M, Tabrizi SN, Phillips S, Danielewski J, Cornall A, Morre SA, Garland SM.

J Med Microbiol. 2018 Oct 10. doi: 10.1099/jmm.0.000836. [Epub ahead of print]

PMID:
30303481
43.

Development of a pilot proficiency program for human papillomavirus DNA detection.

Costa AG, Escott R, Garland SM, Byers D, Tabrizi SN.

Pathology. 2018 Oct;50(6):659-664. doi: 10.1016/j.pathol.2018.05.005. Epub 2018 Aug 20.

PMID:
30139535
44.

Detection of Chlamydia trachomatis mRNA using digital PCR as a more accurate marker of viable organism.

Phillips S, Vodstrcil LA, Huston WM, Lawerence A, Timms P, Chen MY, Worthington K, McIver R, Bradshaw CS, Garland SM, Tabrizi SN, Hocking JS.

Eur J Clin Microbiol Infect Dis. 2018 Nov;37(11):2117-2122. doi: 10.1007/s10096-018-3347-y. Epub 2018 Aug 14.

PMID:
30109584
45.

HLA and KIR Associations of Cervical Neoplasia.

Bao X, Hanson AL, Madeleine MM, Wang SS, Schwartz SM, Newell F, Pettersson-Kymmer U, Hemminki K, Tiews S, Steinberg W, Rader JS, Castro F, Safaeian M, Franco EL, Coutlée F, Ohlsson C, Cortes A, Marshall M, Mukhopadhyay P, Cremin K, Johnson LG, Garland SM, Tabrizi SN, Wentzensen N, Sitas F, Trimble C, Little J, Cruickshank M, Frazer IH, Hildesheim A, Brown MA, Duncan EL, Sun YP, Leo PJ.

J Infect Dis. 2018 Nov 5;218(12):2006-2015. doi: 10.1093/infdis/jiy483.

46.

The new screening program to prevent cervical cancer using HPV DNA: getting the balance right in maintaining quality.

Garland SM, Dimech W, Collignon P; Australian Clinical Microbiologists Infectious Diseases Group, Cooley L, Nimmo GR, Smith DW, Baird R, Rawlinson W, Costa AM, Higgins G.

J Pathol Clin Res. 2018 Oct;4(4):207-212. doi: 10.1002/cjp2.110. Epub 2018 Sep 11.

47.

Cellular Immune Responses 6 Years Following 1, 2, or 3 Doses of Quadrivalent HPV Vaccine in Fijian Girls and Subsequent Responses to a Dose of Bivalent HPV Vaccine.

Toh ZQ, Cheow KWB, Russell FM, Hoe E, Reyburn R, Fong J, Tuivaga E, Ratu FT, Nguyen CD, Matanitobua S, Reitsma A, Tabrizi SN, Garland SM, Mulholland EK, Licciardi PV.

Open Forum Infect Dis. 2018 Jun 20;5(7):ofy147. doi: 10.1093/ofid/ofy147. eCollection 2018 Jul.

48.

Follow-up study of HPV58 variants in women with incident HPV58 infection from a Colombian cohort.

Molano M, Buitrago O, Moreno-Acosta P, Garland SM, Morales N, Huertas A, Martinez T, Gamboa O, Tabrizi SN, Cornall A, Muñoz N.

Oncol Lett. 2018 Aug;16(2):2511-2516. doi: 10.3892/ol.2018.8928. Epub 2018 Jun 8.

49.

Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Females 15-26 Years of Age.

Garland SM, Joura EA, Ault KA, Bosch FX, Brown DR, Castellsagué X, Ferenczy A, Ferris DG, Giuliano AR, Hernandez-Avila M, Huh WK, Iversen OE, Kjaer SK, Kurman RJ, Luna J, Monsonego J, Muñoz N, Paavonen J, Pitisuttihum P, Ronnett BM, Steben M, Stoler MH, Wheeler CM, Wiley DJ, Perez G, Saah AJ, Luxembourg A, Li S, DiNubile MJ, Wagner M, Velicer C.

Obstet Gynecol. 2018 Aug;132(2):261-270. doi: 10.1097/AOG.0000000000002736.

PMID:
29995724
50.

Outcomes of Resistance-guided Sequential Treatment of Mycoplasma genitalium Infections: A Prospective Evaluation.

Read TRH, Fairley CK, Murray GL, Jensen JS, Danielewski J, Worthington K, Doyle M, Mokany E, Tan L, Chow EPF, Garland SM, Bradshaw CS.

Clin Infect Dis. 2019 Feb 1;68(4):554-560. doi: 10.1093/cid/ciy477.

Supplemental Content

Loading ...
Support Center